Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.
Br J Cancer
; 105(7): 890-6, 2011 Sep 27.
Article
em En
| MEDLINE
| ID: mdl-21878937
ABSTRACT
BACKGROUND:
This study aims to identify prognostic factors and to develop a risk model predicting survival in patients undergoing secondary cytoreductive surgery (SCR) for recurrent epithelial ovarian cancer.METHODS:
Individual data of 1100 patients with recurrent ovarian cancer of a progression-free interval at least 6 months who underwent SCR were pooled analysed. A simplified scoring system for each independent prognostic factor was developed according to its coefficient. Internal validation was performed to assess the discrimination of the model.RESULTS:
Complete SCR was strongly associated with the improvement of survival, with a median survival of 57.7 months, when compared with 27.0 months in those with residual disease of 0.1-1 cm and 15.6 months in those with residual disease of >1 cm, respectively (P<0.0001). Progression-free interval (≤23.1 months vs >23.1 months, hazard ratio (HR) 1.72; score 2), ascites at recurrence (present vs absent, HR 1.27; score 1), extent of recurrence (multiple vs localised disease, HR 1.38; score 1) as well as residual disease after SCR (R1 vs R0, HR 1.90, score 2; R2 vs R0, HR 3.0, score 4) entered into the risk model.CONCLUSION:
This prognostic model may provide evidence to predict survival benefit from secondary cytoreduction in patients with recurrent ovarian cancer.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Ovarianas
/
Ovariectomia
/
Neoplasias do Endométrio
/
Cistadenocarcinoma Seroso
/
Adenocarcinoma de Células Claras
/
Adenocarcinoma Mucinoso
/
Recidiva Local de Neoplasia
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Br J Cancer
Ano de publicação:
2011
Tipo de documento:
Article